SG10201603901UA - Methods For Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells And Cardiomyocyte Cells Based On Sirpa Expression - Google Patents
Methods For Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells And Cardiomyocyte Cells Based On Sirpa ExpressionInfo
- Publication number
- SG10201603901UA SG10201603901UA SG10201603901UA SG10201603901UA SG10201603901UA SG 10201603901U A SG10201603901U A SG 10201603901UA SG 10201603901U A SG10201603901U A SG 10201603901UA SG 10201603901U A SG10201603901U A SG 10201603901UA SG 10201603901U A SG10201603901U A SG 10201603901UA
- Authority
- SG
- Singapore
- Prior art keywords
- cardiomyocyte
- methods
- stem cell
- pluripotent stem
- cells
- Prior art date
Links
- 210000004413 cardiac myocyte Anatomy 0.000 title 2
- 101150036449 SIRPA gene Proteins 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37766510P | 2010-08-27 | 2010-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201603901UA true SG10201603901UA (en) | 2016-07-28 |
Family
ID=45722784
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013014303A SG188306A1 (en) | 2010-08-27 | 2011-08-26 | Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression |
| SG10201603901UA SG10201603901UA (en) | 2010-08-27 | 2011-08-26 | Methods For Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells And Cardiomyocyte Cells Based On Sirpa Expression |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013014303A SG188306A1 (en) | 2010-08-27 | 2011-08-26 | Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9994821B2 (en) |
| EP (1) | EP2609194B1 (en) |
| JP (4) | JP6199740B2 (en) |
| CN (1) | CN103189502A (en) |
| AU (1) | AU2011293052A1 (en) |
| CA (1) | CA2809498C (en) |
| DK (1) | DK2609194T3 (en) |
| ES (1) | ES2724198T3 (en) |
| SG (2) | SG188306A1 (en) |
| WO (1) | WO2012024782A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140329314A1 (en) * | 2011-03-29 | 2014-11-06 | Christopher O'Sullivan | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
| WO2012162741A1 (en) * | 2011-06-01 | 2012-12-06 | Monash University | Enrichment of cardiomyocytes |
| JP6373253B2 (en) * | 2012-07-17 | 2018-08-15 | 国立大学法人京都大学 | New cardiomyocyte marker |
| JP6429280B2 (en) * | 2013-05-14 | 2018-11-28 | 国立大学法人京都大学 | Efficient cardiomyocyte induction method |
| AU2014321101B2 (en) * | 2013-09-13 | 2020-12-03 | University Health Network | Methods and compositions for generating epicardium cells |
| EP3097186B1 (en) | 2014-01-21 | 2019-05-08 | The Medical College of Wisconsin, Inc. | Methods for selective inhibition of pluripotent stem cells |
| WO2015172037A1 (en) * | 2014-05-09 | 2015-11-12 | Becton, Dickinson And Company | Cell surface signature for processing cardiomyocyte subsets from heterogeneous cell samples |
| JP2016067243A (en) * | 2014-09-29 | 2016-05-09 | 国立大学法人鳥取大学 | Methods for acquiring myocardial cells derived from pluripotent stem cells |
| US12146161B2 (en) | 2015-02-11 | 2024-11-19 | The Hosptial For Sick Children | Mammalian alveolar macrophages derived from pluripotent cells |
| EP3256569B2 (en) | 2015-02-11 | 2024-04-17 | The Hospital for Sick Children | Alveolar-like macrophages and method of generating same |
| HK1248270A1 (en) | 2015-02-17 | 2018-10-12 | 大学健康网路 | Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes |
| JP2017108705A (en) * | 2015-12-18 | 2017-06-22 | 国立大学法人京都大学 | Method for producing cardiomyocytes |
| JP7089484B2 (en) | 2016-06-01 | 2022-06-22 | ミルテニイ ビオテック ベー．ファー． ウント コー．カーゲー | Methods for Generating, Identifying and Isolating Cardiomyocytes and Cardiomyocyte Subpopulations Derived from Human Pluripotent Stem Cells |
| JOP20190009A1 (en) | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | Antibodies against signal-regulatory protein alpha and methods of use |
| JP6886195B2 (en) * | 2016-09-30 | 2021-06-16 | 京都府公立大学法人 | Methods for Producing Somatic Cells, Somatic Cells, and Compositions |
| KR20250007020A (en) * | 2016-12-04 | 2025-01-13 | 유니버시티 헬스 네트워크 | Generating atrial and ventricular cardiomyocyte lineages from human pluripotent stem cells |
| WO2018156734A1 (en) * | 2017-02-24 | 2018-08-30 | Trustees Of Boston University | Isolation of human lung progenitors derived from pluripotent stem cells |
| ES2963157T3 (en) | 2017-07-26 | 2024-03-25 | Forty Seven Inc | Anti-SIRP-alpha antibodies and related methods |
| US12168028B2 (en) | 2017-09-22 | 2024-12-17 | University Of Miami | Methods for obtaining cardiomyogenic precursor cells |
| PE20201265A1 (en) | 2018-03-21 | 2020-11-19 | Alx Oncology Inc | ANTIBODIES AGAINST SIGNAL REGULATORY ALPHA PROTEIN AND METHODS OF USE |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| US11555179B2 (en) | 2019-02-01 | 2023-01-17 | The University Of Hong Kong | Identification of subpopulations of cardiomyocytes |
| WO2020191500A1 (en) | 2019-03-28 | 2020-10-01 | The Hospital For Sick Children | Method of generating hemangioblasts |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1226233T3 (en) | 1999-08-05 | 2011-10-03 | Abt Holding Co | Multipotent adult stem cells and methods for isolation thereof |
| AU784618B2 (en) | 1999-12-28 | 2006-05-18 | Kyowa Hakko Kogyo Co. Ltd. | Cells capable of differentiating into heart muscle cells |
| US7732199B2 (en) | 2001-07-12 | 2010-06-08 | Geron Corporation | Process for making transplantable cardiomyocytes from human embryonic stem cells |
| WO2003046141A2 (en) | 2001-11-26 | 2003-06-05 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| DE10242338A1 (en) | 2002-09-09 | 2004-03-18 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | New monoclonal antibodies, for identifying and isolating neuronal mesenchymal stem cells, useful in transplantation to regenerate e.g. bone, cartilage or muscle |
| EP1725654B1 (en) * | 2004-03-19 | 2019-05-01 | Asterias Biotherapeutics, Inc. | Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
| CN101020081A (en) * | 2007-03-16 | 2007-08-22 | 重庆大学 | Cell transplating composition for repairing infarcted cardiac muscle and reconstructing blood vessel |
| GB2465502B (en) | 2007-07-31 | 2013-06-26 | Es Cell Int Pte Ltd | Method for identifying and selecting cardiomyocytes |
| US20120288481A1 (en) * | 2009-11-09 | 2012-11-15 | The Brigham And Women's Hospital, Inc. | Treatment of heart disease |
| WO2012162741A1 (en) * | 2011-06-01 | 2012-12-06 | Monash University | Enrichment of cardiomyocytes |
-
2011
- 2011-08-26 CN CN2011800519910A patent/CN103189502A/en active Pending
- 2011-08-26 AU AU2011293052A patent/AU2011293052A1/en not_active Abandoned
- 2011-08-26 US US13/819,318 patent/US9994821B2/en active Active
- 2011-08-26 WO PCT/CA2011/000965 patent/WO2012024782A1/en not_active Ceased
- 2011-08-26 JP JP2013525094A patent/JP6199740B2/en active Active
- 2011-08-26 ES ES11819236T patent/ES2724198T3/en active Active
- 2011-08-26 SG SG2013014303A patent/SG188306A1/en unknown
- 2011-08-26 DK DK11819236.8T patent/DK2609194T3/en active
- 2011-08-26 SG SG10201603901UA patent/SG10201603901UA/en unknown
- 2011-08-26 CA CA2809498A patent/CA2809498C/en active Active
- 2011-08-26 EP EP11819236.8A patent/EP2609194B1/en active Active
-
2016
- 2016-11-28 JP JP2016229933A patent/JP2017038623A/en active Pending
-
2018
- 2018-05-11 US US15/977,505 patent/US20190322986A1/en not_active Abandoned
- 2018-09-25 JP JP2018179338A patent/JP2018201522A/en active Pending
- 2018-09-25 JP JP2018179337A patent/JP2018196399A/en active Pending
-
2020
- 2020-04-13 US US16/847,597 patent/US20200239848A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9994821B2 (en) | 2018-06-12 |
| ES2724198T3 (en) | 2019-09-09 |
| CN103189502A (en) | 2013-07-03 |
| CA2809498A1 (en) | 2012-03-01 |
| EP2609194A4 (en) | 2014-02-19 |
| SG188306A1 (en) | 2013-04-30 |
| EP2609194A1 (en) | 2013-07-03 |
| JP2013535975A (en) | 2013-09-19 |
| US20190322986A1 (en) | 2019-10-24 |
| AU2011293052A1 (en) | 2013-03-28 |
| EP2609194B1 (en) | 2019-01-16 |
| JP2018196399A (en) | 2018-12-13 |
| CA2809498C (en) | 2020-03-31 |
| JP6199740B2 (en) | 2017-09-20 |
| JP2018201522A (en) | 2018-12-27 |
| US20130230921A1 (en) | 2013-09-05 |
| JP2017038623A (en) | 2017-02-23 |
| US20200239848A1 (en) | 2020-07-30 |
| DK2609194T3 (en) | 2019-05-06 |
| WO2012024782A1 (en) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201603901UA (en) | Methods For Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells And Cardiomyocyte Cells Based On Sirpa Expression | |
| IL288185A (en) | Novel methods and culture media for culturing pluripotent stem cells | |
| ZA201708538B (en) | Methods for purifying cells derived from pluripotent stem cells | |
| SG10201500674YA (en) | Pluripotent stem cells | |
| PL2611907T3 (en) | Differentiation of pluripotent stem cells | |
| IL241882B (en) | Methods and compositions for culturing endoderm progenitor cells in suspension | |
| SG10201709546YA (en) | Populations of hematopoietic progenitors and methods of enriching stem cells therefor | |
| PL2893001T3 (en) | Method for culturing mesenchymal stem cells | |
| EP2691512A4 (en) | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells | |
| EP3060650A4 (en) | Culturing pluripotent stem cells | |
| BRPI1011127A2 (en) | methods for growing stem cells and progenitor cells | |
| EP2904103B8 (en) | Method for preparing induced pluripotent stem cells and its applications | |
| IL221481A0 (en) | Method of efficiently establishing induced pluripotent stem cells | |
| ZA201408092B (en) | Cell culture compositions and methods for polypeptide production | |
| GB201117469D0 (en) | Culture media for pluripotent stem cells | |
| SG11201401188QA (en) | Method for producing megakaryocytes and/or platelets from pluripotent stem cells | |
| EP2513297A4 (en) | Materials and methods for generating pluripotent stem cells | |
| EP2700707A4 (en) | Cell culture method and cell culture kit | |
| EP2762559A4 (en) | Melanocyte or progenitor cell thereof adapted to keratinocyte, and preparation method thereof | |
| WO2010096264A9 (en) | Methods for enhancing hematopoietic stem/progenitor cell engraftment | |
| IL231668A0 (en) | Method for the ex vivo expansion of hematopoietic stem and progenitor cells | |
| SG11201406622UA (en) | An in vitro method for culturing stem cells | |
| ZA201504388B (en) | Method for culturing pluripotent stem cells | |
| EP2616081A4 (en) | Method for mobilizing stem and/or progenitor cells | |
| EP2294182A4 (en) | Multipotent stem cell cultures |